Drug
Everolimus NDC Codes
Everolimus is listed in the FDA NDC Directory as 66 finished products from 12 labelers.
Overview
Active ingredient: Everolimus. Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Generic name
- Everolimus; Everolimus tablets
- Active ingredients
- Everolimus
- Labelers
- Biocon Pharma Inc., Breckenridge Pharmaceutical, Inc., Hikma Pharmaceuticals USA Inc., Natco Pharma Limited, i3 Pharmaceuticals, LLC, Novugen Pharma (USA) LLC., Aurobindo Pharma Limited, NorthStar RxLLC, Ascend Laboratories, LLC, ANI Pharmaceuticals, Inc.
- Strengths
- Everolimus 5 mg/1; Everolimus .5 mg/1; Everolimus 1 mg/1; Everolimus .25 mg/1; Everolimus .75 mg/1; Everolimus 2.5 mg/1; Everolimus 7.5 mg/1; Everolimus 10 mg/1; Everolimus 2 mg/1; Everolimus 3 mg/1
- Dosage forms
- Tablet, Tablet, For suspension
- Routes
- Oral
- Drug classes (FDA established)
- Kinase Inhibitor, mTOR Inhibitor Immunosuppressant
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 116
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|
| Everolimus | Everolimus .25 mg/1 | TabletOral | i3 Pharmaceuticals, LLC | 72319-003 | 72319-0003-0272319-0003-60 | — |
| Everolimus | Everolimus .5 mg/1 | TabletOral | i3 Pharmaceuticals, LLC | 72319-015 | 72319-0015-0272319-0015-60 | — |
| Everolimus | Everolimus .75 mg/1 | TabletOral | i3 Pharmaceuticals, LLC | 72319-016 | 72319-0016-0272319-0016-60 | — |
| Everolimus | Everolimus 1 mg/1 | TabletOral | i3 Pharmaceuticals, LLC | 72319-017 | 72319-0017-0272319-0017-60 | — |
| everolimus | Everolimus 2.5 mg/1 | TabletOral | Novugen Pharma (USA) LLC. | 82293-030 | 82293-0030-1082293-0030-2182293-0030-31 | — |
| everolimus | Everolimus 5 mg/1 | TabletOral | Novugen Pharma (USA) LLC. | 82293-031 | 82293-0031-1082293-0031-2182293-0031-31 | — |
| everolimus | Everolimus 7.5 mg/1 | TabletOral | Novugen Pharma (USA) LLC. | 82293-032 | 82293-0032-1082293-0032-2182293-0032-31 | — |
| everolimus | Everolimus 10 mg/1 | TabletOral | Novugen Pharma (USA) LLC. | 82293-033 | 82293-0033-1082293-0033-2182293-0033-31 | — |
| everolimus | Everolimus .25 mg/1 | TabletOral | Aurobindo Pharma Limited | 59651-931 | 59651-0931-60 | — |
| everolimus | Everolimus .5 mg/1 | TabletOral | Aurobindo Pharma Limited | 59651-932 | 59651-0932-60 | — |
| everolimus | Everolimus .75 mg/1 | TabletOral | Aurobindo Pharma Limited | 59651-933 | 59651-0933-60 | — |
| everolimus | Everolimus 1 mg/1 | TabletOral | Aurobindo Pharma Limited | 59651-934 | 59651-0934-60 | — |
| Everolimus | Everolimus 2 mg/1 | Tablet, For suspensionOral | Biocon Pharma Inc. | 70377-090 | 70377-0090-1170377-0090-23 | — |
| Everolimus | Everolimus 3 mg/1 | Tablet, For suspensionOral | Biocon Pharma Inc. | 70377-091 | 70377-0091-1170377-0091-23 | — |
| Everolimus | Everolimus 5 mg/1 | Tablet, For suspensionOral | Biocon Pharma Inc. | 70377-092 | 70377-0092-1170377-0092-23 | — |
| Everolimuseverolimus tablets | Everolimus 1 mg/1 | TabletOral | Breckenridge Pharmaceutical, Inc. | 51991-985 | 51991-0985-0651991-0985-99 | — |
| Everolimus | Everolimus 2 mg/1 | Tablet, For suspensionOral | ANI Pharmaceuticals, Inc. | 70954-773 | 70954-0773-20 | — |
| Everolimus | Everolimus 3 mg/1 | Tablet, For suspensionOral | ANI Pharmaceuticals, Inc. | 70954-774 | 70954-0774-20 | — |
| Everolimus | Everolimus 5 mg/1 | Tablet, For suspensionOral | ANI Pharmaceuticals, Inc. | 70954-775 | 70954-0775-20 | — |
| Everolimus | Everolimus .25 mg/1 | TabletOral | Biocon Pharma Inc. | 70377-069 | 70377-0069-1170377-0069-12 | — |
| Everolimus | Everolimus .5 mg/1 | TabletOral | Biocon Pharma Inc. | 70377-070 | 70377-0070-1170377-0070-21 | — |
| Everolimus | Everolimus .75 mg/1 | TabletOral | Biocon Pharma Inc. | 70377-071 | 70377-0071-1170377-0071-12 | — |
| Everolimus | Everolimus 1 mg/1 | TabletOral | Biocon Pharma Inc. | 70377-112 | 70377-0112-1170377-0112-21 | — |
| Everolimus | Everolimus 2 mg/1 | Tablet, For suspensionOral | Breckenridge Pharmaceutical, Inc. | 51991-990 | 51991-0990-2851991-0990-77 | — |
| Everolimus | Everolimus 3 mg/1 | Tablet, For suspensionOral | Breckenridge Pharmaceutical, Inc. | 51991-991 | 51991-0991-2851991-0991-77 | — |
| Everolimus | Everolimus 5 mg/1 | Tablet, For suspensionOral | Breckenridge Pharmaceutical, Inc. | 51991-992 | 51991-0992-2851991-0992-77 | — |
| Everolimus | Everolimus 2 mg/1 | Tablet, For suspensionOral | Amneal Pharmaceuticals NY LLC | 60219-2279 | 60219-2279-02 | — |
| Everolimus | Everolimus 3 mg/1 | Tablet, For suspensionOral | Amneal Pharmaceuticals NY LLC | 60219-2280 | 60219-2280-02 | — |
| Everolimus | Everolimus 5 mg/1 | Tablet, For suspensionOral | Amneal Pharmaceuticals NY LLC | 60219-2281 | 60219-2281-02 | — |
| Everolimus | Everolimus 2.5 mg/1 | TabletOral | NorthStar RxLLC | 72603-254 | 72603-0254-01 | — |
| Everolimus | Everolimus 5 mg/1 | TabletOral | NorthStar RxLLC | 72603-255 | 72603-0255-01 | — |
| Everolimus | Everolimus 7.5 mg/1 | TabletOral | NorthStar RxLLC | 72603-256 | 72603-0256-01 | — |
| Everolimus | Everolimus 10 mg/1 | TabletOral | NorthStar RxLLC | 72603-257 | 72603-0257-01 | — |
| Everolimus | Everolimus .5 mg/1 | TabletOral | Par Health USA, LLC | 49884-159 | 49884-0159-02 | — |
| Everolimus | Everolimus 1 mg/1 | TabletOral | Par Health USA, LLC | 49884-283 | 49884-0283-02 | — |
| Everolimus | Everolimus .25 mg/1 | TabletOral | Ascend Laboratories, LLC | 67877-718 | 67877-0718-3167877-0718-60 | — |
| Everolimus | Everolimus .5 mg/1 | TabletOral | Ascend Laboratories, LLC | 67877-719 | 67877-0719-3167877-0719-60 | — |
| Everolimus | Everolimus .75 mg/1 | TabletOral | Ascend Laboratories, LLC | 67877-720 | 67877-0720-3167877-0720-60 | — |
| Everolimus | Everolimus 1 mg/1 | TabletOral | Ascend Laboratories, LLC | 67877-721 | 67877-0721-3167877-0721-60 | — |
| Everolimus | Everolimus 1 mg/1 | TabletOral | Hikma Pharmaceuticals USA Inc. | 0054-0604 | 00054-0604-21 | — |
| Everolimus | Everolimus 10 mg/1 | TabletOral | Natco Pharma Limited | 63850-0061 | 63850-0061-0163850-0061-04 | — |
| Everolimus | Everolimus 2.5 mg/1 | TabletOral | Biocon Pharma Inc. | 70377-010 | 70377-0010-1170377-0010-2270377-0010-23 | — |
| Everolimus | Everolimus 5 mg/1 | TabletOral | Biocon Pharma Inc. | 70377-011 | 70377-0011-1170377-0011-2270377-0011-23 | — |
| Everolimus | Everolimus 7.5 mg/1 | TabletOral | Biocon Pharma Inc. | 70377-012 | 70377-0012-1170377-0012-2270377-0012-23 | — |
| Everolimus | Everolimus 10 mg/1 | TabletOral | Biocon Pharma Inc. | 70377-013 | 70377-0013-1170377-0013-2270377-0013-23 | — |
| Everolimuseverolimus tablets | Everolimus .25 mg/1 | TabletOral | Breckenridge Pharmaceutical, Inc. | 51991-379 | 51991-0379-0651991-0379-60 | — |
| Everolimuseverolimus tablets | Everolimus .5 mg/1 | TabletOral | Breckenridge Pharmaceutical, Inc. | 51991-380 | 51991-0380-0651991-0380-60 | — |
| Everolimuseverolimus tablets | Everolimus .75 mg/1 | TabletOral | Breckenridge Pharmaceutical, Inc. | 51991-381 | 51991-0381-0651991-0381-60 | — |
| Everolimus | Everolimus .25 mg/1 | TabletOral | Natco Pharma Limited | 63850-0062 | 63850-0062-0263850-0062-06 | — |
| Everolimus | Everolimus .5 mg/1 | TabletOral | Natco Pharma Limited | 63850-0063 | 63850-0063-0263850-0063-06 | — |
Everolimus: common questions
- What is the NDC for Everolimus?
- Everolimus has 66 product NDCs, one for each strength, dosage form and labeler; each product NDC then has one package NDC per package size. Pick the row for your product above to see its package NDCs.
- Is there a J-code for Everolimus?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.